The GSK, Amgen and Novo-backed cancer drug developer went public in an upsized offering priced above its range.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Neil Woodford has reportedly joined former WIM chief executive Craig Newman at Juno Capital to form a portfolio of unquoted healthcare stocks.

MIT-founded biochemical water treatment company Solugen has increased its funding total to at least $48.7m.

The second quarter total is up from $185m the previous year and $392m quarter-on-quarter despite coronavirus-driven pressures.

Primary care network Oak Street Health has filed for a $100m offering on the New York Stock Exchange that will give Humana an exit.

Memorial Sloan Kettering spinout Paige’s series B total stands at $70m following a third tranche featuring Goldman Sachs and Healthcare Venture Partners.

3B Future Health Fund has participated in the cancer drug developer’s $5.8m extension round, investing alongside returning backers including M Ventures.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

A total of 23 biopharmaceutical producers have committed capital to the vehicle, which will provide funding for the creation of new antibiotics.